The American Society of Anesthesiologists has signed a regulatory comment letter to the Department of Justice, recommending they review DEA regulations involving quotas of controlled substances.
According to the release, an ASA work group has identified the current quota system as one cause of drug shortages. The letter states, "We firmly support the department's plan to evaluate regulations that apply to quotas to registered manufacturers of Schedule I and II controlled substances and certain List I chemicals found in 21 C.F.R. §§ 1303, 1315. We believe the current regulations of controlled substances, and in particular the quota system, have negatively impacted patients across America by contributing to the number and duration of drug shortages."
The letter was signed by eight organizations and businesses, including the American Hospital Association, the American Society of Clinical Oncology, the American Society of Health-System Pharmacists and the Generic Pharmaceutical Association.
Read the ASA release on the letter to the DEA.
Related Articles on Anesthesia:
Anesthesiologist Dr. Richard Bowe Discusses Technological Advances, Lessons From the Recession
Physicians Frequently Over-Ventilate Pediatric Patients During CPR
White Paper on Anesthesia Onboarding and Change Management Published by Somnia Anesthesia
According to the release, an ASA work group has identified the current quota system as one cause of drug shortages. The letter states, "We firmly support the department's plan to evaluate regulations that apply to quotas to registered manufacturers of Schedule I and II controlled substances and certain List I chemicals found in 21 C.F.R. §§ 1303, 1315. We believe the current regulations of controlled substances, and in particular the quota system, have negatively impacted patients across America by contributing to the number and duration of drug shortages."
The letter was signed by eight organizations and businesses, including the American Hospital Association, the American Society of Clinical Oncology, the American Society of Health-System Pharmacists and the Generic Pharmaceutical Association.
Read the ASA release on the letter to the DEA.
Related Articles on Anesthesia:
Anesthesiologist Dr. Richard Bowe Discusses Technological Advances, Lessons From the Recession
Physicians Frequently Over-Ventilate Pediatric Patients During CPR
White Paper on Anesthesia Onboarding and Change Management Published by Somnia Anesthesia